These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 29571066

  • 1. In vitro and in vivo evaluation of the bifunctional chelator NODIA-Me in combination with a prostate-specific membrane antigen targeting vector.
    Läppchen T, Kiefer Y, Holland JP, Bartholomä MD.
    Nucl Med Biol; 2018 May; 60():45-54. PubMed ID: 29571066
    [Abstract] [Full Text] [Related]

  • 2. Gallium Complexation, Stability, and Bioconjugation of 1,4,7-Triazacyclononane Derived Chelators with Azaheterocyclic Arms.
    Schmidtke A, Läppchen T, Weinmann C, Bier-Schorr L, Keller M, Kiefer Y, Holland JP, Bartholomä MD.
    Inorg Chem; 2017 Aug 07; 56(15):9097-9110. PubMed ID: 28742337
    [Abstract] [Full Text] [Related]

  • 3. Assessment of PSMA targeting ligands bearing novel chelates with application to theranostics: Stability and complexation kinetics of 68Ga3+, 111In3+, 177Lu3+ and 225Ac3.
    Kelly JM, Amor-Coarasa A, Nikolopoulou A, Kim D, Williams C, Vallabhajosula S, Babich JW.
    Nucl Med Biol; 2017 Dec 07; 55():38-46. PubMed ID: 29055836
    [Abstract] [Full Text] [Related]

  • 4. Preparation and preclinical evaluation of a 68Ga-labelled c(RGDfK) conjugate comprising the bifunctional chelator NODIA-Me.
    Läppchen T, Holland JP, Kiefer Y, Bartholomä MD.
    EJNMMI Radiopharm Chem; 2018 Dec 07; 3(1):6. PubMed ID: 29756024
    [Abstract] [Full Text] [Related]

  • 5. 68Ga-complex lipophilicity and the targeting property of a urea-based PSMA inhibitor for PET imaging.
    Eder M, Schäfer M, Bauder-Wüst U, Hull WE, Wängler C, Mier W, Haberkorn U, Eisenhut M.
    Bioconjug Chem; 2012 Apr 18; 23(4):688-97. PubMed ID: 22369515
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and evaluation of a novel urea-based 68Ga-complex for imaging PSMA binding in tumor.
    Zha Z, Ploessl K, Choi SR, Wu Z, Zhu L, Kung HF.
    Nucl Med Biol; 2018 Apr 18; 59():36-47. PubMed ID: 29459281
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Proof-of-Concept Study of the NOTI Chelating Platform: Preclinical Evaluation of 64Cu-Labeled Mono- and Trimeric c(RGDfK) Conjugates.
    Martin S, Maus S, Stemler T, Rosar F, Khreish F, Holland JP, Ezziddin S, Bartholomä MD.
    Mol Imaging Biol; 2021 Feb 18; 23(1):95-108. PubMed ID: 32856224
    [Abstract] [Full Text] [Related]

  • 10. 61Cu-PSMA-Targeted PET for Prostate Cancer: From Radiotracer Development to First-in-Human Imaging.
    Basaco Bernabeu T, Mansi R, Del Pozzo L, Zanger S, Gaonkar RH, McDougall L, De Rose F, Jaafar-Thiel L, Herz M, Eiber M, Ulaner GA, Weber WA, Fani M.
    J Nucl Med; 2024 Sep 03; 65(9):1427-1434. PubMed ID: 39025646
    [Abstract] [Full Text] [Related]

  • 11. Synthesis and pre-clinical evaluation of a new class of high-affinity 18F-labeled PSMA ligands for detection of prostate cancer by PET imaging.
    Kelly J, Amor-Coarasa A, Nikolopoulou A, Kim D, Williams C, Ponnala S, Babich JW.
    Eur J Nucl Med Mol Imaging; 2017 Apr 03; 44(4):647-661. PubMed ID: 27847991
    [Abstract] [Full Text] [Related]

  • 12. Preclinical Comparative Study of (68)Ga-Labeled DOTA, NOTA, and HBED-CC Chelated Radiotracers for Targeting PSMA.
    Ray Banerjee S, Chen Z, Pullambhatla M, Lisok A, Chen J, Mease RC, Pomper MG.
    Bioconjug Chem; 2016 Jun 15; 27(6):1447-55. PubMed ID: 27076393
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. (R)-NODAGA-PSMA: A Versatile Precursor for Radiometal Labeling and Nuclear Imaging of PSMA-Positive Tumors.
    Gourni E, Canovas C, Goncalves V, Denat F, Meyer PT, Maecke HR.
    PLoS One; 2015 Jun 15; 10(12):e0145755. PubMed ID: 26700033
    [Abstract] [Full Text] [Related]

  • 15. Design and Preclinical Evaluation of an Albumin-Binding PSMA Ligand for 64Cu-Based PET Imaging.
    Umbricht CA, Benešová M, Hasler R, Schibli R, van der Meulen NP, Müller C.
    Mol Pharm; 2018 Dec 03; 15(12):5556-5564. PubMed ID: 30376344
    [Abstract] [Full Text] [Related]

  • 16. Synthesis and Evaluation of 68Ga- and 177Lu-Labeled (R)- vs (S)-DOTAGA Prostate-Specific Membrane Antigen-Targeting Derivatives.
    Zhao R, Ploessl K, Zha Z, Choi S, Alexoff D, Zhu L, Kung HF.
    Mol Pharm; 2020 Dec 07; 17(12):4589-4602. PubMed ID: 33108189
    [Abstract] [Full Text] [Related]

  • 17. Novel [68Ga/177Lu]Ga/Lu-AZ-093 as PSMA-Targeting Agent for Diagnosis and Radiotherapy.
    Wang R, Jin W, Luo Y, Hong H, Zhao R, Li L, Yan L, Qiao J, Ploessl K, Zhu L, Kung HF.
    Mol Pharm; 2024 Jul 01; 21(7):3256-3267. PubMed ID: 38856975
    [Abstract] [Full Text] [Related]

  • 18. Preclinical Evaluation of a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate Cancer.
    Benešová M, Schäfer M, Bauder-Wüst U, Afshar-Oromieh A, Kratochwil C, Mier W, Haberkorn U, Kopka K, Eder M.
    J Nucl Med; 2015 Jun 01; 56(6):914-20. PubMed ID: 25883127
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and biological evaluation of copper-64 radiolabeled [DUPA-6-Ahx-(NODAGA)-5-Ava-BBN(7-14)NH2], a novel bivalent targeting vector having affinity for two distinct biomarkers (GRPr/PSMA) of prostate cancer.
    Bandari RP, Jiang Z, Reynolds TS, Bernskoetter NE, Szczodroski AF, Bassuner KJ, Kirkpatrick DL, Rold TL, Sieckman GL, Hoffman TJ, Connors JP, Smith CJ.
    Nucl Med Biol; 2014 Apr 01; 41(4):355-63. PubMed ID: 24508213
    [Abstract] [Full Text] [Related]

  • 20. Development of Novel PSMA Ligands for Imaging and Therapy with Copper Isotopes.
    Carlos Dos Santos J, Beijer B, Bauder-Wüst U, Schäfer M, Leotta K, Eder M, Benešová M, Kleist C, Giesel F, Kratochwil C, Kopka K, Haberkorn U, Mier W.
    J Nucl Med; 2020 Jan 01; 61(1):70-79. PubMed ID: 31541034
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.